Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Overexpression of apelin in Wharton’ jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats

  • 1,
  • 1,
  • 1,
  • 1,
  • 2,
  • 1 and
  • 1Email author
Stem Cell Research & Therapy201910:6

https://doi.org/10.1186/s13287-018-1116-6

  • Received: 19 December 2018
  • Accepted: 19 December 2018
  • Published:

The original article was published in Stem Cell Research & Therapy 2018 9:339

Correction to: Stem Cell Res Ther

https://doi.org/10.1186/s13287-018-1084-x

The original article [1] contained errors in the presentation of Figure 7. These have now been corrected.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Center of Cardiology, The Sixth Medical Center of P.L.A. General Hospital (Former Navy General Hospital), NO.6 Fucheng Road, Beijing, Haidian District, 100048, People’s Republic of China
(2)
Department of Internal Medicine, The 413th Hospital of P.L.A., 98 Wenhua Road, Zhoushan, Zhejiang, 316000, People’s Republic of China

Reference

  1. Gao LR, et al. Overexpression of apelin in Wharton’ jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats. Stem Cell Res Ther. 2018;9:339 https://doi.org/10.1186/s13287-018-1084-x.View ArticleGoogle Scholar

Copyright

© The Author(s). 2019

Advertisement